PE Tech Report

NEWSLETTER

Like this article?

Sign up to our free newsletter

Mountaingate completes investment in ImagineSoftware

Buy and build middle market private equity firm Mountaingate Capital (Mountaingate) has made a strategic investment in ImagineSoftware, a revenue cycle management SaaS platform.

Founded in 2000 by CEO Sam Khashman, ImagineSoftware now bills for over 46,000 physicians in Radiology, Anesthesia, Emergency Medicine, Pathology, Oncology, and over 18 other specialties with end-to-end practice and revenue cycle management software solutions. ImagineSoftware is partnering with Mountaingate to accelerate its growth organically as well as through selective strategic acquisitions.
 
“We are very excited to partner with Sam and Imagine’s deep and passionate leadership team. Imagine is a forward-thinking leader in helping billing companies and medical practices streamline and improve billing efforts,” says Stew Fisher, Managing Director of Mountaingate. “The company’s relentless focus on its customers’ success truly sets it apart and has positioned the company for continued growth.”
 
“One of our early customers exclaimed ‘If you can imagine it, they can do it’ and it set the stage for our culture and focus ever since. The partnership with Mountaingate will help Imagine achieve our next stage of growth and permit us to further accelerate innovation through resources and capabilities,” says Khashman. “After an extensive search for a business partner who aligns with Imagine’s client-focus, and our culture, Mountaingate’s track record and their experience in partnering with entrepreneurs provided the right partnership for us. We are thrilled to have their support and are very excited about the next chapter of our growth and the growth of our customers.”
 
ImagineSoftware was advised by Adelphi Capital and law firm Nexsen Pruet, while Mountaingate was advised by law firm Kirkland & Ellis. Varagon Capital Partners and NewStar Financial provided additional financing for the transaction.

Like this article? Sign up to our free newsletter

MOST POPULAR

FURTHER READING

Featured